ArticleFrontiers in pharmacology2022

Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study.

Yong-Shuai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.